Abstract
Neoplastic meningitis (NM) occurs in approximately 8% of all cancer patients. To confirm a clinical impression that NM is relatively common in patients who undergo surgical resection of an isolated cerebellar metastasis (ICM), a retrospective studywas performed. All patients who underwent a surgical resection of an isolated CNS metastasis at The Johns Hopkins Hospital betweenJanuary 1991 and June 1993 were identified. Their charts, laboratoryand pathologic data, radiologic studies, survival andcause of death were reviewed. A total of 66 patients were identified. Fifty-five patients underwent a surgical resectionof a supratentorial metastasis while 11 patients (6 females and5 males) underwent a surgical resection of an isolated cerebellarmetastasis. The ages of patients with cerebellar metastases rangedfrom 23 to 74 years at the time of diagnosis with a median age of49 years. All 11 patients had stable systemic disease and an excellent performance status. Five patients had tumors from lung,2 from breast, and 4 from other sites. Each was expected to have a long survival. However, 4 of the 11 patients (36%)developed unequivocal NM at 1, 3, 6, and 7 months following surgicalresection and all died within 1 month from the diagnosisof NM. Two patients had a positive CSF cytology and the other two had multiple enhancing leptomeningeal metastases on MRI. Two additionalpatients died of progressive neurological disease without evidence of local recurrence, yet were never formally evaluated for NM and two were lost to follow-up. Thus, the incidence of NM in this patient population is at least 36%. In the 55 patientswho had resections of supratentorial metastases, only 1 patient (2%) developed NM. This study suggests thatNM following surgical resection of an ICM may be common and mayresult in the premature demise of patients with excellent performancestatus, minimal systemic disease, and a reasonable life expectancy.Further studies are needed to determine if prophylacticintrathecal chemotherapy administered perioperatively could diminish the incidence of clinically apparent NM in this patient population.
Similar content being viewed by others
References
Azzarelli B, Mirkin LD, Goheen M, Muller J, Crockett C: The leptomeningeal vein: A site of re-entry of leukemic cells into the systemic circulation. Cancer 54: 1333–1343, 1984
Gonzalez-Vitale JC, Garcia-Bunuel R: Meningeal carcinomatosis. Cancer 37: 2906–2911, 1976
Grossman SA, Moynihan TJ: Neoplastic meningitis. Neurol Clin 9: 843–856, 1991
Posner JB, Chernik NL: Intracranial metastases from systemic cancer. Adv Neurol 19: 579–592, 1978
Phillips PC, Than TT, Cork LC, Hilton J, Carson BS, Colvin OM, Grochow LB: Intrathecal 4-hydroperoxycyclophosphamide: Neurotoxicity, cerebral fluid pharmacokinetics, and antitumor activity in rabbit model of VX2 leptomeningeal carcinomatosis. Cancer Res 52: 6168–6174, 1992
Posner JB: Brain metastases: A clinician's view. In: Weiss L, Gilbert HA, Posner JB (eds) Brain Metastases, GK Hall, Boston 2–29, 1980
Galicich JH: Surgery of malignant brain tumors. In: Vick N (ed) Seminars in Neurology 1, Thieme-Stratton, New York 159–168, 1981
Galicich JH, Sundaresan N, Arbit E, Passe S: Surgical treatment of single brain metastasis: Factors associated with survival. Cancer 45: 381–386, 1980
Sandaresan N, Galicich JH, Beattie EJ: Surgical treatment of brain metastases from lung cancer. J Neurosurg 58: 666–671, 1983
Winston KR, Walsh JW, Fischer EG: Results of operative treeatment of intracranial metastatic tumors. Cancer 45: 2639–2645, 1980
Lang EF Jr, Slater J: Metastatic brain tumors: Results of surgical and non-surgical treatment. Surg Clin North Am 44: 865–872, 1964
Cairncross JG, Kim J-H, Posner JB: Radiation therapy for brain metastases. Ann Neurol 7: 529–541, 1980
Cairncross JG, Posner JB: The management of brain metastases. In: Walker MD (ed) Oncology of the Nervous System, Vol 12 of Cancer Treatment and Research, Martinus Nijhoff, Boston 341–377, 1983
Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B: A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322: 494–500, 1990
Takakura K, Sana K, Kojo S, Hirano A: Metastatic tumors of the central nervous system. Tokyo, Igaku-Shoin, 1982. Reproduced from Wright DC: Surgical treatment of brain metastasis. In: Rosenberg SA (ed) Surgical Treatment of Metastatic Cancer, JB Lippincott, Philadelphia 165–222, 1987
Kitaoka K, Abe H, Aida T, Satoh M, Itoh T, Nakagawa Y: Follow-up study on metastatic cerebellar tumor surgery: Characteristic problems of surgical treatment. Neurol Med Chir 30: 591–598, 1990
Posner JB: Intracranial metastases. In: Reinhardt RW, Wissler BM (eds) Neurologic Complications of Cancer, FA Davis Company, Philadelphia p 102, 1995
Mirimanoff RO, Choi NC: The risk of intradural spinal metastases in patients with brain metastases from bronchogenic carcinomas. Int J Radiat Oncol Biol Phys 12: 2131–2136, 1986
Mirimanoff RO, Choi NC: Intradural spinal metastases in patients with posterior fossa brain metastases from various primary cancers. Oncology 44: 232–236, 1987
Morton DL: Principles of surgical oncology. In: Holland JF, Frei E III, Bast RC Jr, Kufe DW, Morton DL, Weichselbaum RR (eds) Cancer Medicine, ed 3, Lea & Febiger, Philadelphia 523–538, 1993
Mayo WJ: Grafting and traumatic dissemination of carcinoma in course of operations for malignant disease. JAMA 60: 512–513, 1913
Umpleby HC, Williamson RCN: Anastomotic recurrence in large bowel cancer. Br J Surg 74: 873–878, 1987
Pollett WG, Nicholls RJ: The relationship between the extent of distal clearance and survival and local recurrence rates after curative anterior resection for carcinoma of the rectum. Ann Surg 198: 159–163, 1983
Williams NS, Dixon MF, Johnston D: Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: A study of distal intramural spread and of patients' survival. Br J Surg 70: 150–154, 1983
Fisher ER, Turnbull RB: The cytologic demonstration and significance of tumor cells in the mesenteric venous blood in patients with colorectal carcinoma. Surg Gynecol Obstet 100: 102–108, 1955
Rubio CA, Nylander G, Wallin B, Sveander M, Alun M-L, Duvander A: Carcinogenesis at colonic anastomosis sites. Dis Colon Rectum 27: 468–470, 1984
Nogueras JJ, Jagelman DG: Principles of resection: Influence of surgical treatment on treatment outcome. Surg Clin North Am 73: 103–116, 1993
Mimura H, Takakura N, Kim H, Hamazaki K, Tsuge H, Ochiai Y: Block resection of hepatoduodenal ligament for carcinoma of the bile duct and gallbladder: Surgical technique and a report of 11 cases. Hepatogastroenterology 38: 561–567, 1991
Grossman SA, Finkelstein DM, Ruckdeschel JC, Trump DL, Moynihan T, Ettinger DS: Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. J Clin Onc 11: 561–569, 1993
Trump DL, Grossman SA, Thompson G, Murray K, Wharam M: Treatment of neoplastic meningitis with intraventricular thiotepa and methotrexate. Cancer Treat Rep 66: 1549–1551, 1982
Posner JB: Reservoirs for intraventricular chemotherapy. N Engl J Med 288: 212, 1973
Lishner M, Perrin RG, Feld R, Messner HA, Tuffnell PG, Elhakim T, Matlow A, Curtis JE: Complications associated with ommaya reservoirs in patients with cancer. The Princess Margaret Hospital experience and a review of the literature. Arch Intern Med 150: 173–176, 1990
Bleyer WA: Current status of intrathecal chemotherapy for human meningeal neoplasms. Natl Cancer Inst Monogr 46: 171–178, 1977
Ettinger LJ, Chervinsky DS, Freeman AI, Creaven PJ: Pharmacokinetics of methotrexate following intravenous and intraventricular administration in acute lymphocytic leukemia and non-Hodgkin's lymphoma. Cancer 50: 1676–1682, 1982
Winkelman MD, Jines JD: Cerebellar degeneration caused by high dose cytosine arabinoside: A clinicopathological study. Ann Neurol 14: 520–527, 1983
Gutin PH, Weiss HD, Wiernik PH, Walker MD: Intrathecal N,N′,N″-triethylenethiophosphoramide [thio-TEPA (NSC 6396]) in the treatment of malignant meningeal disease: Phase I–II study. Cancer 38: 1471–1475, 1976
Wasserstrom WR, Glass JP, Posner JB: Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients. Cancer 49: 759–772, 1982
Olson ME, Chernik NL, Posner JB: Infiltration of the leptomeninges by systemic cancer: A clinical and pathologic study. Arch Neurol 30: 122–137, 1974
Boyle R, Thomas M, Adams JH: Diffuse involvement of the leptomeninges by tumour: A clinical and pathological study of 63 cases. Postgrad Med J 56: 149–158, 1980
Grossman SA, Trump DL, Chen DCP, Thompson G, Camargo EE: Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitis–an evaluation using 111-indium-DTPA ventriculography. Am J Med 73: 641–647, 1982
Evans AE, Gilbert ES, Zandstra R: The increasing incidence of central nervous system leukemia in children. Cancer 26: 404–409, 1970
Simone J, Aur RJ, Husto HO, Pinkel D: Total therapy: Studies of acute lymphocytic leukemia in children. Cancer 30: 1488–1494, 1972
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Norris, L.K., Grossman, S.A. & Olivi, A. Neoplastic meningitis following surgical resection of isolated cerebellar metastasis: A potentially preventable complication. J Neurooncol 32, 215–223 (1997). https://doi.org/10.1023/A:1005723801479
Issue Date:
DOI: https://doi.org/10.1023/A:1005723801479